COVID-19 y complicaciones cardiovasculares

Autores/as

DOI:

https://doi.org/10.35381/s.v.v6i1.1721

Palabras clave:

Fármacos cardiovasculares, sistema cardiovascular, fenómenos fisiológicos cardiovasculares. (Fuente, DeCS).

Resumen

Objetivo: Analizar el COVID - 19 y complicaciones cardiovasculares. Método: revisión sistemática. Análisis de los resultados: Una gran proporción de pacientes tiene enfermedad cardiovascular subyacente y factores de riesgo cardíaco. Los factores asociados con la mortalidad incluyen el sexo masculino, la edad avanzada y la presencia de comorbilidades como las enfermedades cardiovasculares. La lesión cardíaca aguda determinada por niveles elevados de troponina de alta sensibilidad se observa comúnmente en casos graves y está fuertemente asociada con la mortalidad, al igual que el síndrome de dificultad respiratoria aguda. Conclusión: La infección por el SARS-CoV-2 presenta una baja mortalidad en la mayoría de los casos, pero un porcentaje significativo de los infectados sufren una enfermedad pulmonar con diferentes grados de afección sistémica que sí conlleva mayor mortalidad. Estos pacientes presentan grados variables de afección miocárdica, tanto directa por el virus como por la situación sistémica grave, que incrementan el riesgo de muerte.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Álvarez Moreno, Yadira, Bú Figueroa, Janeth, Bú Figueroa, Efraín, Soto Fonseca, Marco, Escober Torres, Javier, Trombosis de arteria carótida interna en COVID 19. Colombia Médica [Internet]. 2020; 51 (3). Recuperado de: https://www.redalyc.org/articulo.oa?id=28365569006

Arno R Bourgonje , Amaal E Abdulle , Wim Timens , Jan-Luuk Hillebrands , Gerjan J Navis , Sanne J Gordijn , Marieke C Bolling , Gerard Dijkstra , Adriaan A Voors , Albert DME Osterhaus , Peter HJ van der Voort , Douwe J Mulder , Harry van Goor. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol 2020; 251: 228–248. doi: org/10.1002/path.5471

Huang X, Wei F, Hu L, Wen L, Chen K. Epidemiology and Clinical Characteristics of COVID-19. Arch Iran Med. 2020 Apr 1;23(4):268-271. doi: 10.34172/aim.2020.09. PMID: 32271601.

Liu J, Liao X, Qian S, Yuan J, Wang F, Liu Y, Wang Z, Wang FS, Liu L, Zhang Z. Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis. 2020 Jun;26(6):1320-1323. doi: 10.3201/eid2606.200239. Epub 2020 Jun 17. PMID: 32125269; PMCID: PMC7258448.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;: PMID: 31986264; PMCID: PMC7159299.

Li J, Gong X, Wang Z, Chen R, Li T, Zeng D, Li M. Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China. Virus Res. 2020 Sep;286:198043. doi: 10.1016/j.virusres.2020.198043. Epub 2020 Jun 2. PMID: 32502551; PMCID: PMC7265838.

Wu J, Li J, Zhu G, Zhang Y, Bi Z, Yu Y, Huang B, Fu S, Tan Y, Sun J, Li X. Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1139-1145. doi: 10.2215/CJN.04160320. Epub 2020 May 22. PMID: 32444393; PMCID: PMC7409740.

Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T. Neurological associations of COVID-19. Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2. PMID: 32622375; PMCID: PMC7332267.

Aziz S, Arabi YM, Alhazzani W, Evans L, Citerio G, Fischkoff K, Salluh J, Meyfroidt G, Alshamsi F, Oczkowski S, Azoulay E, Price A, Burry L, Dzierba A, Benintende A, Morgan J, Grasselli G, Rhodes A, Møller MH, Chu L, Schwedhelm S, Lowe JJ, Bin D, Christian MD. Managing ICU surge during the COVID-19 crisis: rapid guidelines. Intensive Care Med. 2020 Jul;46(7):1303-1325. doi: 10.1007/s00134-020-06092-5. Epub 2020 Jun 8. PMID: 32514598; PMCID: PMC7276667.

Joebges S, Biller-Andorno N. Ethics guidelines on COVID-19 triage-an emerging international consensus. Crit Care. 2020 May 6;24(1):201. doi: 10.1186/s13054-020-02927-1. PMID: 32375855; PMCID: PMC7202791.

Shovlin CL, Vizcaychipi MP. Implications for COVID-19 triage from the ICNARC report of 2204 COVID-19 cases managed in UK adult intensive care units. Emerg Med J. 2020 Jun;37(6):332-333. doi: 10.1136/emermed-2020-209791. Epub 2020 May 4. PMID: 32366619.

Swiss Academy Of Medical Sciences. COVID-19 pandemic: triage for intensive-care treatment under resource scarcity. Swiss Med Wkly. 2020 Mar 24;150:w20229. doi: 10.4414/smw.2020.20229. PMID: 32208495.

Leclerc T, Donat N, Donat A, Pasquier P, Libert N, Schaeffer E, D'Aranda E, Cotte J, Fontaine B, Perrigault PF, Michel F, Muller L, Meaudre E, Veber B. Prioritisation of ICU treatments for critically ill patients in a COVID-19 pandemic with scarce resources. Anaesth Crit Care Pain Med. 2020 Jun;39(3):333-339. doi: 10.1016/j.accpm.2020.05.008. Epub 2020 May 17. PMID: 32426441; PMCID: PMC7230138.

Lamblin A, de Montgolfier S. COVID-19 and ethical considerations: Valuable decision-making tools from the leading medical societies in France. Anaesth Crit Care Pain Med. 2020 Jun;39(3):365-366. doi: 10.1016/j.accpm.2020.05.001. Epub 2020 May 7. PMID: 32414630; PMCID: PMC7204662.

Kim SYH, Grady C. Ethics in the time of COVID: What remains the same and what is different. Neurology. 2020 Jun 9;94(23):1007-1008. doi: 10.1212/WNL.0000000000009520. Epub 2020 Apr 6. PMID: 32253351; PMCID: PMC7455363.

Umakanthan S, Sahu P, Ranade AV, Bukelo MM, Rao JS, Abrahao-Machado LF, Dahal S, Kumar H, Kv D. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020 Dec;96(1142):753-758. doi: 10.1136/postgradmedj-2020-138234. Epub 2020 Jun 20. PMID: 32563999.

Parasher A. COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgrad Med J. 2021 May;97(1147):312-320. doi: 10.1136/postgradmedj-2020-138577. Epub 2020 Sep 25. PMID: 32978337.

Li YD, Chi WY, Su JH, Ferrall L, Hung CF, Wu TC. Coronavirus vaccine development: from SARS and MERS to COVID-19. J Biomed Sci. 2020 Dec 20;27(1):104. doi: 10.1186/s12929-020-00695-2. PMID: 33341119; PMCID: PMC7749790.

Atzrodt CL, Maknojia I, McCarthy RDP, Oldfield TM, Po J, Ta KTL, Stepp HE, Clements TP. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2. FEBS J. 2020 Sep;287(17):3633-3650. doi: 10.1111/febs.15375. Epub 2020 Jun 16. PMID: 32446285; PMCID: PMC7283703.

Yao TT, Qian JD, Zhu WY, Wang Y, Wang GQ. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option. J Med Virol. 2020 Jun;92(6):556-563. doi: 10.1002/jmv.25729. Epub 2020 Mar 12. PMID: 32104907; PMCID: PMC7217143.

Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020 Jul 1;5(7):831-840. doi: 10.1001/jamacardio.2020.1286. PMID: 32219363.

Voulalas G, Tsui J, Candilio L, Baker D. SARS-CoV-2 and Pre-existing Vascular Diseases: Guilt by Association? Clin Med Insights Cardiol. 2021 May 16;15:11795468211010705. doi: 10.1177/11795468211010705. PMID: 34035654; PMCID: PMC8132081.

Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6;: PMID: 32125452; PMCID: PMC7080116.

Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648. PMID: 32091533.

Salazar M, Barochiner J, Espeche W, Ennis I. COVID-19, hipertensión y enfermedad cardiovascular [COVID-19 and its relationship with hypertension and cardiovascular disease]. Hipertens Riesgo Vasc. 2020 Oct-Dec;37(4):176-180. Spanish. doi: 10.1016/j.hipert.2020.06.003. PMID: 32591283; PMCID: PMC7301092.

Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020 May 14;41(19):1798-1800. doi: 10.1093/eurheartj/ehaa231. PMID: 32186331; PMCID: PMC7454513.

Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020 May-Jun;14(3):247-250. doi: 10.1016/j.dsx.2020.03.013. Epub 2020 Mar 25. PMID: 32247212; PMCID: PMC7102662.

Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020 1;5(7):831-840. doi: 10.1001/jamacardio.2020.1286. PMID: 32219363.

Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017. Erratum in: JAMA Cardiol. 2020 Jul 1;5(7):848. PMID: 32219356; PMCID: PMC7101506.

Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: Possible mechanisms. Life Sci. 2020 Jul 15;253:117723. doi: 10.1016/j.lfs.2020.117723. Epub 2020 Apr 28. PMID: 32360126; PMCID: PMC7194533.

Unudurthi SD, Luthra P, Bose RJC, McCarthy JR, Kontaridis MI. Cardiac inflammation in COVID-19: Lessons from heart failure. Life Sci. 2020 Nov 1;260:118482. doi: 10.1016/j.lfs.2020.118482. Epub 2020 Sep 21. PMID: 32971105; PMCID: PMC7505073.

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950. PMID: 32211816; PMCID: PMC7097841.

Li JW, Han TW, Woodward M, Anderson CS, Zhou H, Chen YD, Neal B. The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis. Prog Cardiovasc Dis. 2020 Jul-Aug;63(4):518-524. doi: 10.1016/j.pcad.2020.04.008. Epub 2020 Apr 16. PMID: 32305557; PMCID: PMC7160645.

Descargas

Publicado

01-03-2022

Cómo citar

Viteri-Rodríguez, J. A., Iglesias-Espín, D. S., & Palacios-Paredes, M. R. (2022). COVID-19 y complicaciones cardiovasculares. Revista Arbitrada Interdisciplinaria De Ciencias De La Salud. Salud Y Vida, 6(1), 178–195. https://doi.org/10.35381/s.v.v6i1.1721

Número

Sección

Original breve

Artículos más leídos del mismo autor/a

<< < 1 2 3 4